Citigroup Initiates Coverage on Reckitt Benckiser Group (OTCMKTS:RBGLY)

Analysts at Citigroup began coverage on shares of Reckitt Benckiser Group (OTCMKTS:RBGLYGet Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “buy” rating on the stock.

RBGLY has been the subject of several other research reports. Royal Bank Of Canada lowered Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a report on Monday, October 27th. Barclays raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Monday, December 1st. Jefferies Financial Group reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a research note on Wednesday, January 7th. Finally, Morgan Stanley cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 15th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Get Our Latest Analysis on RBGLY

Reckitt Benckiser Group Price Performance

Shares of OTCMKTS:RBGLY opened at $16.39 on Wednesday. The firm has a fifty day moving average price of $15.97 and a two-hundred day moving average price of $15.33. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37. Reckitt Benckiser Group has a one year low of $11.83 and a one year high of $16.80.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.